Oncology & Cancer
Study shows promising results for immunotherapy targeting skin cancer
A new class of immunotherapy shows promising results for fighting the most aggressive form of skin cancer.
Apr 25, 2023
0
72
News tagged withovarian cancers
Oncology & Cancer
HRD detection predicts sensitivity to platinum-based chemotherapy for ovarian cancer patients in China
Homologous Recombination Deficiency (HRD) is a biomarker that predicts ovarian cancer treatment with PARP inhibitors or breast cancer treatment with first-line platinum-based chemotherapy. However, limited research is documented ...
Apr 25, 2023
0
5
Oncology & Cancer
Cancer therapy: Gene silencing of cytoskeleton-associated protein 5 in genetically unstable cancer cells
The therapeutic potential of microtubule-associated protein targets for cancer therapy is a largely unexplored research area due to a lack of target-specific agents. Sushmita Chatterjee and a research team in nanomedicine, ...
Oncology & Cancer
Exome sequencing identifies those with cancer predisposition syndromes missed by current screening guidelines
Among individuals who consented to whole-exome sequencing and were identified as carriers of predisposition genes for hereditary breast and ovarian cancer (HBOC) or Lynch syndrome, 39.2% would not have qualified for genetic ...
Apr 18, 2023
0
3
Obstetrics & gynaecology
Research finds removing ovaries at benign hysterectomy carries health risks
An emulated target trial of more than 140,000 women in Denmark found that removing the ovaries at benign hysterectomy was associated with increased risk for cardiovascular disease in younger women and cancer in older women ...
Apr 18, 2023
0
2
Obstetrics & gynaecology
Preclinical study identifies new target for recurrent ovarian cancer
Despite recent advances, ovarian cancer remains the fifth leading cause of cancer-related deaths among women, and there's a critical need for new treatment options, especially for advanced cancers that grow back after standard ...
Apr 17, 2023
0
45
Oncology & Cancer
Researchers report results in rare gynecologic cancers from DART immunotherapy trial
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus nivolumab in 53 cohorts of patients with rare cancers, are being reported for five cohorts of patients who had rare ...
Apr 17, 2023
0
15
Oncology & Cancer
研究人员确定专业mising new target for drug-resistant breast and ovarian cancers
CU Boulder researchers have discovered a protein's crucial role in helping breast and ovarian tumors survive and thrive and have found that suppressing that protein kills cancer cells without harming healthy ones.
Apr 13, 2023
0
47
